US 12263180
Method for treatment of COVID-19-associated conditions
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 12263180 (Method for treatment of COVID-19-associated conditions) held by Rigel Pharmaceuticals, Inc. expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K31/155, A61K31/245